The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may be proposed. A validated prognostic index (PI) would help in evaluating and choosing these treatments. Characteristics at diagnosis were collected from 4167 patients with FL diagnosed between 1985 and 1992. Univariate and multivariate analyses were used to propose a PI. This index was then tested on 919 patients. Five adverse prognostic factors were selected: age (> 60 years vs < or = 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs > or = 120 g/L), number of nodal areas (> 4 vs < or = 4), and serum LDH level (above normal vs normal or below). Three risk groups were defined: low risk (0-1 adverse factor, 36% of patients), intermediate risk (2 factors, 37% of patients, hazard ratio [HR] of 2.3), and poor risk (> or = 3 adverse factors, 27% of patients, HR = 4.3). This Follicular Lymphoma International Prognostic Index (FLIPI) appeared more discriminant than the International Prognostic Index proposed for aggressive non-Hodgkin lymphomas. Results were very similar in the confirmation group. The FLIPI may be used for improving treatment choices, comparing clinical trials, and designing studies to evaluate new treatments.

Follicular lymphoma international prognostic index / SOLAL CELIGNY, P; Roy, P; Colombat, P; White, J; Armitage, Jo; ARRANZ SAEZ, R; Au, Wy; Bellei, Monica; Brice, P; Caballero, D; Coiffier, B; CONDE GARCIA, E; Doyen, C; Federico, Massimo; Fisher, Ri; GARCIA CONDE, Jf; Guglielmi, C; Hagenbeek, A; Haioun, C; Leblanc, M; Lister, At; LOPEZ GUILLERMO, A; Mclaughlin, P; Milpied, N; Morel, P; Mounier, N; Proctor, Sj; Rohatiner, A; Smith, P; Soubeyran, P; Tilly, H; Vitolo, U; Zinzani, Pl; Zucca, E; Montserrat, E.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 104 (5):(2004), pp. 1258-1265. [10.1182/blood-2003-12-4434]

Follicular lymphoma international prognostic index.

BELLEI, Monica;FEDERICO, Massimo;
2004

Abstract

The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may be proposed. A validated prognostic index (PI) would help in evaluating and choosing these treatments. Characteristics at diagnosis were collected from 4167 patients with FL diagnosed between 1985 and 1992. Univariate and multivariate analyses were used to propose a PI. This index was then tested on 919 patients. Five adverse prognostic factors were selected: age (> 60 years vs < or = 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs > or = 120 g/L), number of nodal areas (> 4 vs < or = 4), and serum LDH level (above normal vs normal or below). Three risk groups were defined: low risk (0-1 adverse factor, 36% of patients), intermediate risk (2 factors, 37% of patients, hazard ratio [HR] of 2.3), and poor risk (> or = 3 adverse factors, 27% of patients, HR = 4.3). This Follicular Lymphoma International Prognostic Index (FLIPI) appeared more discriminant than the International Prognostic Index proposed for aggressive non-Hodgkin lymphomas. Results were very similar in the confirmation group. The FLIPI may be used for improving treatment choices, comparing clinical trials, and designing studies to evaluate new treatments.
104 (5)
1258
1265
Follicular lymphoma international prognostic index / SOLAL CELIGNY, P; Roy, P; Colombat, P; White, J; Armitage, Jo; ARRANZ SAEZ, R; Au, Wy; Bellei, Monica; Brice, P; Caballero, D; Coiffier, B; CONDE GARCIA, E; Doyen, C; Federico, Massimo; Fisher, Ri; GARCIA CONDE, Jf; Guglielmi, C; Hagenbeek, A; Haioun, C; Leblanc, M; Lister, At; LOPEZ GUILLERMO, A; Mclaughlin, P; Milpied, N; Morel, P; Mounier, N; Proctor, Sj; Rohatiner, A; Smith, P; Soubeyran, P; Tilly, H; Vitolo, U; Zinzani, Pl; Zucca, E; Montserrat, E.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 104 (5):(2004), pp. 1258-1265. [10.1182/blood-2003-12-4434]
SOLAL CELIGNY, P; Roy, P; Colombat, P; White, J; Armitage, Jo; ARRANZ SAEZ, R; Au, Wy; Bellei, Monica; Brice, P; Caballero, D; Coiffier, B; CONDE GARCIA, E; Doyen, C; Federico, Massimo; Fisher, Ri; GARCIA CONDE, Jf; Guglielmi, C; Hagenbeek, A; Haioun, C; Leblanc, M; Lister, At; LOPEZ GUILLERMO, A; Mclaughlin, P; Milpied, N; Morel, P; Mounier, N; Proctor, Sj; Rohatiner, A; Smith, P; Soubeyran, P; Tilly, H; Vitolo, U; Zinzani, Pl; Zucca, E; Montserrat, E.
File in questo prodotto:
File Dimensione Formato  
Follicular lymphoma......pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 412.69 kB
Formato Adobe PDF
412.69 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/584210
Citazioni
  • ???jsp.display-item.citation.pmc??? 347
  • Scopus 1365
  • ???jsp.display-item.citation.isi??? 1216
social impact